Rabizadeh Soghra, Hajmiri Minoosadat, Rajab Armin, Emadi Kouchak Hamid, Nakhjavani Manouchehr
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Infectious Disease and Tropical Medicine, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1241-1243. doi: 10.1515/jpem-2020-0296.
Objectives Recently, World Health Organization has declared coronavirus disease 2019 (COVID-19) infection a pandemic. Patients with diabetes may be at an increased risk of developing COVID-19 infection, as well as increased risk of morbidity and mortality. Although the current data have shown that the coronavirus infection generally has a milder course in children. Case presentation In this case report, we present a teenage patient with severe diabetic ketoacidosis (DKA) as the first manifestation of his diabetes and COVID-19 infection. Conclusions He was treated for DKA and COVID-19 infection, and fortunately, had a good response to the treatment.
目标 最近,世界卫生组织已宣布2019冠状病毒病(COVID-19)感染为大流行病。糖尿病患者感染COVID-19的风险可能会增加,发病和死亡风险也会增加。尽管目前的数据表明冠状病毒感染在儿童中通常病程较轻。病例报告 在本病例报告中,我们介绍了一名青少年患者,其严重糖尿病酮症酸中毒(DKA)是其糖尿病和COVID-19感染的首发表现。结论 他接受了DKA和COVID-19感染的治疗,幸运的是,对治疗反应良好。